Oncology Equipment Supplied In Australasia

Automate Your Workflow With Breakthrough Sterile Drug Compounding Technology. Introducing Diana, the first user-controlled automated compounding system with barcode scanning for the safe preparation of IV medications, including hazardous drugs. The Diana™ system helps you reduce the risk for exposure to hazardous drugs while maintaining drug sterility and minimizing physical stress to ...

Maximize efficiency and safety by remotely verifying every mix without having to gown up and enter the cleanroom. Diana is the first and only system to combine both automated compounding and IV workflow technologies with wireless pharmacist notification to let you remotely verify each preparation on a handheld tablet display. Integrated high-definition cameras let you visualize the workflow for ...

With the lowest cost to implement, ChemoClave makes the decision to start improving IV medication safety a whole lot easier. We know that the cost of implementing a CSTD into clinical practice can be a deciding factor in the purchasing process. That’s why we developed the ChemoClave needlefree CSTD to not only help you minimize hazardous drug exposure and maximize medication safety, but to ...

Treating cancer patients takes compassion—it shouldn’t take a toll on your health. But the fact is, while chemotherapy is the backbone of medical oncology, these powerful medications—along with many others—are extremely toxic to the clinicians who handle them. Prolonged exposure to hazardous drug vapors, drips, or spills has been shown to lead to hair ...

DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug used to treat colorectal cancer with peak global ...

We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular nature of the antibody structure, the same panel of antibody sequences can be used to generate a variety of therapeutic antibody formats including, but not limited to, ...

Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...

The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...

Chosen more often than any other to provide an effective barrier against bacterial transfer and standardize clinical protocols for all patients and care areas. Help enhance safety and efficiency by choosing industry-leading infection control technology. When you choose ICU Medical needlefree IV sets and connectors with patented Clave™ technology, you get an effective barrier against ...